The raw data would have been given to the company since January when the last subject presented after 6 months. Then it should have been independently reviewed. Frazer would have already gone over it. Who do you think gave AHZ the information for the powerpoint? WP said in the webinar he and Frazer discussed the results.
Ann: Admedus Releases Results of HSV-2 Phase IIa Study, page-101
-
- There are more pages in this discussion • 250 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
0.000(0.00%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.00 | $18.10 | $17.70 | $58.64K | 3.27K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 109 | $18.00 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.10 | 700 | 1 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |